Back to Journals » Neuropsychiatric Disease and Treatment » Volume 9
Worsened hypertension control induced by aripiprazole
Authors Yasui-Furukori N, Akira Fujii
Received 12 February 2013
Accepted for publication 19 March 2013
Published 15 April 2013 Volume 2013:9 Pages 505—507
DOI https://doi.org/10.2147/NDT.S43950
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Norio Yasui-Furukori, Akira Fujii
Department of Neuropsychiatry, Graduate School of Medicine, Hirosaki University, Hirosaki, Japan
Abstract: Aripiprazole is widely used in the treatment of schizophrenia and bipolar disorders. Although antipsychotics generally have hypotensive effects, two cases were identified that demonstrated hypertension during the switch from other antipsychotics to aripiprazole. The hypertensive state of these patients recovered after switching back to other antipsychotics, and these cases suggest that aripiprazole may lead to hypertension.
Keywords: hypertension, aripiprazole, dopamine antagonist, 5-HT1a
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.